Literature DB >> 1573428

Functional status as an overall measure of health in adults with cystic fibrosis: further validation of a generic health measure.

S L Shepherd1, M F Hovell, D J Slymen, I R Harwood, C R Hofstetter, L E Granger, R M Kaplan.   

Abstract

We studied the validity of a generic health measure in a population with a chronic, life-shortening illness. Thirty-seven adults with cystic fibrosis (CF) and 46 of their healthy peers completed a questionnaire which included 12 questions on functional status from the RAND Health Insurance Study. For the CF group, the questionnaire and a medical chart review yielded data on 7 additional health variables, including pulmonary function. After data collection, members of the CF group were followed for 5 years, by which time 11 had died. The functional status of the CF group was significantly lower than that of the comparison group. Within the CF group, functional status correlated significantly with 6 of the 7 other health variables. Analysis using the Cox proportional hazards model showed that functional status alone was a significant (p less than 0.001) predictor of a CF subject's survival time; in a multivariate model a non-significant trend suggested that lowered functional status may be associated with an increased risk of early death even after adjustment for pulmonary function and percent ideal body weight. These results extend previous findings and suggest that functional status can be used as an overall measure of health in a wide variety of studies.

Entities:  

Mesh:

Year:  1992        PMID: 1573428     DOI: 10.1016/0895-4356(92)90004-7

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  A prognostic model for the prediction of survival in cystic fibrosis.

Authors:  K M Hayllar; S G Williams; A E Wise; S Pouria; M Lombard; M E Hodson; D Westaby
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients.

Authors:  Bernadette Henry; Pierre Aussage; Cécile Grosskopf; Jean-Marie Goehrs
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

Review 3.  Quality of life in cystic fibrosis.

Authors:  D E Tullis; G H Guyatt
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

4.  Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis.

Authors:  L Gee; J Abbott; S P Conway; C Etherington; A K Webb
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 5.  Quality of life in cystic fibrosis.

Authors:  J Abbott; K Webb; M Dodd
Journal:  J R Soc Med       Date:  1997       Impact factor: 18.000

6.  Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity?

Authors:  D Staab; K Wenninger; N Gebert; K Rupprath; S Bisson; M Trettin; K D Paul; K M Keller; U Wahn
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.